Moving Beyond the Breast Cancer Screening Debate

National Committee for Quality Assurance (NCQA). Proposed changes to existing measure for HEDIS 2014: Breast Cancer Screening (BCS). https://www.ncqa.org/Portals/0/PublicComment/HEDIS2014/2.%20BCS%20Materials.pdf

American Cancer Society Guidelines for the Early Detection of Cancer. Available at www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer Accessed June 5, 2014 .

Miller AB , Wall C , Baines CJ , et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomized screening trial. BMJ, 2014; 348:g366.

Welch HG , Black WC . Overdiagnosis in cancer. J Natl Cancer Inst, 2010; 102:605–613.

Esserman LJ , Shieh Y , Rutgers EJ , et al. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat, 2011; 130:725–734.

Esserman LJ , Thompson IM Jr. , Reid B . Overdiagnosis and overtreatment in cancer: An opportunity for improvement. JAMA, 2013; 310:797–798.

Esserman LJ , Thompson IM , Reid B , et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol, 2014; 15:e234–242.

Pace LE , Keating NL . A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA, 2014; 311:1327–1335.

Biller-Andorno N , Jüni P . Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med, 2014; 370:1965–1967.

Committee on a Framework for Development a New Taxonomy of Disease; National Research Council. Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: National Academies Press, 2011.

Esserman LJ , Thompson IM , Reid B , et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol, 2014; 15:e234–242.

Flowers CI , O'Donoghue C , Moore D , et al. Reducing false-positive biopsies: A pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat, 2013; 139:769–777.

O'Donoghue C , Eklund M , Ozanne EM , Esserman LJ . Aggregate cost of mammography screening in the United States: Comparison of current practice and advocated guidelines. Ann Intern Med, 2014; 160:145.

Elmore JG , Gross CP . The cost of breast cancer screening in the United States: A picture is worth…a billion dollars?. Ann Intern Med, 2014; 160:203.

Webb ML , Cady B , Michaelson JS , et al. A failure analysis of invasive breast cancer: Most deaths from disease occur in women not regularly screened. Cancer, 2013 [Epub ahead of print]; DOI: 10.1002/cncr.28199

Berry , Donald A . Breast cancer screening: Controversy of impact. Breast, 2013; 22:S73–S76.

Berry DA . Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies. Cancer, 2014. doi: 10.1002/cncr.28795. [Epub ahead of print]

Kopans , Daniel B . Mammograms save lives: Criticism of breast-cancer screenings is more about rationing than rationality. Wall Street Journal, May 22, 2014. Available at http://online.wsj.com/news/article_email/SB10001424052702304547704579564440536353948-lMyQjAxMTA0MDIwMjEyNDIyWj Accessed June, 4, 2014 .

Eklund M , Esserman LJ . Screening: Biology dictates the fate of young women with breast cancer. Nat Rev Clin Oncol, 2013; 10:673–675.